Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical and Translational Science|July 27, 2018
Design and Conduct Considerations for First-in-Human TrialsJie Shen, Brandon Swift, Richard Mamelok, et al.Journal of Clinical Pharmacology|April 25, 2015
Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjectsLinh Nguyen, Jaymes Holland, Richard Mamelok, et al.Clinical Pharmacology in Drug Development|October 15, 2016
Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult SubjectsMichael Burdick, Richard Mamelok, Michele Hurliman, et al.Journal of Clinical Pharmacology|February 12, 2016
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of CabozantinibLinh Nguyen, Jaymes Holland, David Ramies, et al.Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 30, 2009
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipientsBjörn Nashan, Faouzi Saliba, Francois Durand, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2005
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipientsHoward J Eisen, Jon Kobashigawa, Anne Keogh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid LeukemiaPinkal M Desai, Janice Brown, Saar Gill, et al.Pageof 1